Doris M. Benbrook
Affiliations: | Biochemistry and Molecular Biology | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Biochemistry, Cell Biology, Oncology, Medicine and SurgeryGoogle:
"Doris Benbrook"Children
Sign in to add traineeShennan Lu | grad student | 2000 | University of Oklahoma Health Sciences Center |
Suresh Guruswamy | grad student | 2003 | University of Oklahoma Health Sciences Center |
Shylet Chengedza | grad student | 2009 | University of Oklahoma Health Sciences Center |
Chioniso P. Masamha | grad student | 2010 | University of Oklahoma Health Sciences Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rai R, Dey DK, Benbrook DM, et al. (2023) Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 161: 114422 |
Rai R, Chandra V, Kennedy AL, et al. (2022) Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2. Frontiers in Oncology. 12: 958536 |
Benbrook DM. (2022) SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention. Frontiers in Cell and Developmental Biology. 10: 848682 |
Chandra V, Rai R, Benbrook DM. (2021) Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer. Cancers. 13 |
Rai R, Essel KG, Benbrook DM, et al. (2020) Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer. Cancers. 12: 1273 |
Kennedy AL, Rai R, Isingizwe ZR, et al. (2020) Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib. Cancers. 12 |
Sharma A, Li M, Thavathiru E, et al. (2020) Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice. The Aaps Journal. 22: 51 |
Isingizwe ZR, Benbrook DM. (2020) Abstract 2840: Development of a model of dihomo-gamma-linolenic acid interference with platelet promotion of ovarian cancer Tumor Biology |
Vaughn K, Lausen J, Bruns M, et al. (2020) A novel drug inhibits exosome content loading and secretion in ovarian cancer cells The Faseb Journal. 34: 1-1 |
Essel K, Benbrook D, Rai R, et al. (2020) Sulforaphane as a Potential Therapeutic for Endometrial Cancer Gynecologic Oncology. 156: e30 |